# Atlas Antibodies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atlas-antibodies

- Industry: Biotechnology
- Headquarters: Sweden
- Website: www.atlasantibodies.com
- Latest round: Seed (Sep 6, 2006)
- Investors on record: 1

## About

Based in Sweden and established in 2006, Atlas Antibodies AB was originated from the Human Protein Atlas project, Atlas Antibodies engages in providing validated research antibodies intended for biomedical research and development companies. As of 2021, John Daicic Ph.D. is the chief executive officer (CEO) of the company. In July 2021, Atlas Antibodies AB acquired evitria AG.

The company develops and produces primary antibodies, control antigens, and targeted proteomics intended for the research areas including neuroscience, cancer, cell biology, and stem cell research. Atlas Antibodies AB also distributes its products internationally in locations such as Europe excluding Russia, Canada, Australia, New Zealand, Israel, and the US.

Following the acquisition in July 2021, Atlas Antibodies AB will partner with evitria AG to continue commercializing the antibodies developed by the Human Protein Atlas project.

## Funding rounds

- Seed, Sep 6, 2006 — Patricia Industries

## Investors

- Patricia Industries (https://capitalatlas.ai/funds/patricia-industries) — Seed